United States Ovarian Cancer Diagnostics Market Demand, Size and Competitive Analysis | TechSci Research

United States Ovarian Cancer Diagnostics Market was valued at USD 284.13 million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.79% through 2029. <table><tr><td>Pages</td><td>82</td></tr> <tr><td>Market Size</td><td>2023: USD 284.13 million</td></tr> <tr><td>Forecast Market Size</td><td>2029: USD 394.42 million</td></tr> <tr><td>CAGR</td><td>2024-2029: 5.79%</td></tr> <tr><td>Fastest Growing Segment</td><td>Imaging</td></tr> <tr><td>Largest Market</td><td>Mid-West</td></tr> <tr><td>Key Players</td><td>1.Abbott Laboratories Inc.2.F. Hoffmann-La Roche Ltd.3.GlaxoSmithKline plc4.Johnson & Johnson5.AstraZeneca plc6.Siemens Healthcare GmbH7.Quest Diagnostics Incorporated8.Thermo Fisher Scientific Inc9.Bio-Rad Technologies Inc10.Eli Lily and Company</td></tr> </table>

美国卵巢癌诊断市场在2023年达到了2.8413亿美元的规模，预计在预测期内将实现令人瞩目的增长，复合年增长率（CAGR）将达到5.79%，预计到2029年将达到3.9442亿美元。

<table>
<tr>
<td>页数</td><td>82</td>
</tr>
<tr>
<td>市场规模</td><td>2023年：2.8413亿美元</td>
</tr>
<tr>
<td>预测市场规模</td><td>2029年：3.9442亿美元</td>
</tr>
<tr>
<td>复合年增长率</td><td>2024-2029年：5.79%</td>
</tr>
<tr>
<td>增长最快的细分市场</td><td>成像</td>
</tr>
<tr>
<td>最大市场</td><td>中西部</td>
</tr>
<tr>
<td>主要参与者</td><td>1.阿贝托实验室公司2.F. 霍夫曼-拉罗什有限公司3.葛兰素史克公司4.强生公司5.阿斯利康公司6.西门子医疗保健公司7.Quest 诊断公司8.赛默飞世尔科技公司9.生物雷达科技公司10.艾利利公司</td>
</tr>
</table>